药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Orlistat
Flumequine
The therapeutic efficacy of Buformin can be increased when used in combination with Flumequine.
Orlistat
Nemonoxacin
The therapeutic efficacy of Buformin can be increased when used in combination with Nemonoxacin.
Orlistat
Garenoxacin
The therapeutic efficacy of Buformin can be increased when used in combination with Garenoxacin.
Orlistat
Technetium Tc-99m ciprofloxacin
The therapeutic efficacy of Buformin can be increased when used in combination with Technetium Tc-99m ciprofloxacin.
Orlistat
Fleroxacin
The therapeutic efficacy of Buformin can be increased when used in combination with Fleroxacin.
Orlistat
Temafloxacin
The therapeutic efficacy of Buformin can be increased when used in combination with Temafloxacin.
Orlistat
Gemifloxacin
The therapeutic efficacy of Buformin can be increased when used in combination with Gemifloxacin.
Diphenoxylate
Doxifluridine
The risk or severity of adverse effects can be increased when 5-methyltetrahydrofolic acid is combined with Doxifluridine.
Diphenoxylate
Tegafur
The risk or severity of adverse effects can be increased when 5-methyltetrahydrofolic acid is combined with Tegafur.
Diphenoxylate
Uracil
The risk or severity of adverse effects can be increased when 5-methyltetrahydrofolic acid is combined with Uracil.
Diphenoxylate
5-fluorouridine
The risk or severity of adverse effects can be increased when 5-methyltetrahydrofolic acid is combined with 5-fluorouridine.
Diphenoxylate
Capecitabine
The risk or severity of adverse effects can be increased when 5-methyltetrahydrofolic acid is combined with Capecitabine.
Diphenoxylate
Flucytosine
The risk or severity of adverse effects can be increased when 5-methyltetrahydrofolic acid is combined with Flucytosine.
Diphenoxylate
Cycloguanil
The therapeutic efficacy of Cycloguanil can be decreased when used in combination with 5-methyltetrahydrofolic acid.
Diphenoxylate
Brodimoprim
The therapeutic efficacy of Brodimoprim can be decreased when used in combination with 5-methyltetrahydrofolic acid.
Diphenoxylate
Nolatrexed
The therapeutic efficacy of Nolatrexed can be decreased when used in combination with 5-methyltetrahydrofolic acid.
Diphenoxylate
Lometrexol
The therapeutic efficacy of Lometrexol can be decreased when used in combination with 5-methyltetrahydrofolic acid.
Diphenoxylate
Aminopterin
The therapeutic efficacy of Aminopterin can be decreased when used in combination with 5-methyltetrahydrofolic acid.
Diphenoxylate
Pralatrexate
The therapeutic efficacy of Pralatrexate can be decreased when used in combination with 5-methyltetrahydrofolic acid.
Diphenoxylate
Iclaprim
The therapeutic efficacy of Iclaprim can be decreased when used in combination with 5-methyltetrahydrofolic acid.